G. Calais

发表

Atlas-based automatic segmentation (ABAS) of head and neck (H&N) structures in conformal radiotherapy (CRT): Atlas development and preliminary results in clinical context

O. Commowick, G. Malandain, A. Isambert, 2007 .

French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC).

N. Magné, G. Calais, G. Poissonnet, 2006, International journal of radiation oncology, biology, physics.

Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study.

J. Horiot, S. Schraub, G. Calais, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Cetuximab Pharmacokinetics Influences Overall Survival in Patients With Head and Neck Cancer.

G. Calais, G. Paintaud, D. Ternant, 2016, Therapeutic drug monitoring.

Concomitant radiochemotherapy or accelerated radiotherapy: analysis of two randomized trials of the French Head and Neck Cancer Group (GORTEC).

G. Calais, J. Bourhis, C. Sire, 2004, Seminars in oncology.

The Dijon clinical staging system for early rectal carcinomas amenable to intracavitary treatment techniques.

J. Horiot, G. Calais, S. Roth, 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prognostic factors in limited rectal cancer treated with intracavitary irradiation.

J. Horiot, G. Calais, S. Roth, 1989, International journal of radiation oncology, biology, physics.

Complete Pathological Response Following Radiochemotherapy for Locally Advanced Rectal Cancer: Short and Long-term Outcome

G. Calais, S. Guyétant, T. Lecomte, 2019, AntiCancer Research.

What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question?

L. Collette, G. Calais, T. Conroy, 2012, European journal of cancer.

Preoperative radiation (Preop RT) in rectal cancer: Effect and timing of additional chemotherapy (CT) 5-year results of the EORTC 22921 trial

L. Collette, G. Calais, J. Bosset, 2005 .

Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial.

V. Grégoire, G. Calais, J. Bourhis, 2012, The Lancet. Oncology.

Rectal cancer.

G. Calais, G. Roseau, C. Penna, 2006, Gastroenterologie clinique et biologique.

PPA_A_246757 859..868

G. Calais, M. Bollet, C. Sire, 2020 .

Patient Satisfaction with Fentanyl Pectin Nasal Spray in Breakthrough Cancer Pain Management During Radiotherapy for Head and Neck Cancer

G. Calais, M. Bollet, C. Sire, 2020, Patient preference and adherence.

Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma.

G. Calais, C. Sire, J. Tortochaux, 1999, Journal of the National Cancer Institute.

Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study.

G. Calais, J. Bosset, P. Garaud, 2005, International journal of radiation oncology, biology, physics.

Long-term quality of life in patients with rectal cancer treated with preoperative (chemo)-radiotherapy within a randomized trial.

G. Calais, J. Bosset, P. Maingon, 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

An analysis of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer on survival in a pooled analysis of EORTC 22921 and FFCD 9203 trials: Surrogacy in question?

L. Collette, G. Calais, T. Conroy, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neoadjuvant Treatment in Upper Rectal Cancer Does Not Improve Oncologic Outcomes But Increases Postoperative Morbidity

G. Calais, Y. Panis, Z. Lakkis, 2020, AntiCancer Research.

Prognostic Impact of Upfront Surgery for Locally Advanced Upper Rectal Adenocarcinoma

G. Calais, D. Moussata, T. Lecomte, 2021, AntiCancer Research.

Abdomino pelvic irradiation after second-look laparotomy for stage III ovarian carcinoma.

G. Calais, G. Body, J. Lansac, 1995, European journal of obstetrics, gynecology, and reproductive biology.

Preoperative or postoperative brachytherapy for patients with endometrial carcinoma stage I and II.

G. Calais, G. Body, J. Lansac, 1990, International journal of radiation oncology, biology, physics.

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19805 patients, on behalf of MACH-NC group.

B. Jeremic, L. Collette, J. Pignon, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Does the addition of chemotherapy (CT) to preoperative radiotherapy (preopRT) increase the pathological response in patients with resected rectal cancer : Report of the 22921 EORTC phase III trial.

L. Collette, G. Calais, J. Bosset, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radical hysterectomy for stage I and II endometrial carcinoma: a retrospective analysis of 179 cases.

G. Calais, J. Lansac, P. Descamps, 1991, International journal of radiation oncology, biology, physics.

Lymphadenectomy in the management of endometrial carcinoma stage I and II. Retrospective study of 155 cases.

G. Calais, J. Lansac, P. Descamps, 1990, Clinical oncology (Royal College of Radiologists (Great Britain)).

Simultaneous or staged resection for synchronous liver metastasis and primary rectal cancer: a propensity score matching analysis

G. Calais, D. Moussata, P. Bucur, 2022, BMC Gastroenterology.

[Stage III and IV cancers of the oropharynx: results of a randomized study of Gortec comparing radiotherapy alone with concomitant chemotherapy].

G. Calais, C. Sire, J. Tortochaux, 2000, Bulletin du cancer.

Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study.

G. Calais, E. Babin, E. Blot, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trial.

G. Calais, J. Bourhis, C. Sire, 2004, International journal of radiation oncology, biology, physics.

Quality of surgery in T3-4 rectal cancer: involvement of circumferential resection margin not influenced by preoperative treatment. Results from EORTC 22921 trial

L. Collette, G. Calais, C. Marijnen, 2009 .

Quality of surgery in T3-4 rectal cancer: involvement of circumferential resection margin not influenced by preoperative treatment. Results from EORTC trial 22921.

L. Collette, G. Calais, C. Marijnen, 2007, European Journal of Cancer.

Compliance and toxicity profiles of the CARISSA trial of postoperative cisplatin-based chemoradiation ± gefitinib in head and neck cancer.

G. Calais, P. Giraud, J. Thariat, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast-conserving surgery? Results of the ARCOSEIN multicenter, Phase III study: patients' and doctors' views.

G. Calais, M. Bollet, J. Bosset, 2007, International journal of radiation oncology, biology, physics.

Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.

G. Calais, S. Faivre, C. Sire, 2009, Journal of the National Cancer Institute.

Impact of Novel Hormonal Agents (Abiraterone, Enzalutamide) on the Development of Visceral and/or Brain Metastases in Patients With Bone-metastatic Castration-resistant Prostate Cancer.

G. Calais, C. Linassier, G. Fromont, 2022, Clinical genitourinary cancer.

Concomitant chemoradiotherapy using carboplatin, tegafur-uracil and leucovorin for stage III and IV head-and-neck cancer: results of GORTEC Phase II study.

G. Calais, P. Garaud, P. Pommier, 2010, International journal of radiation oncology, biology, physics.

Atlas-based automatic segmentation (ABAS) of head structures in conformal radiation therapy (CRT): atlas development and preliminary results in clinical context

Grégoire Malandain, Olivier Commowick, John A. Mills, 2007 .

Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitations

J. Pignon, G. Calais, J. Bourhis, 2004, Current opinion in oncology.

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19805 patients, on behalf of MACH-NC group.

B. Jeremic, L. Collette, J. Pignon, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent.

G. Calais, J. Bourhis, P. Maingon, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Fatal infusion reactions to cetuximab: role of immunoglobulin e-mediated anaphylaxis.

G. Calais, T. Platts-Mills, H. Watier, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Is lymphadenectomy useful in the treatment of endometrial carcinoma?

G. Calais, G. Body, J. Lansac, 1990, Gynecologic oncology.

Mucoepidermoid carcinoma of salivary glands: A French Network of Rare Head and Neck Tumors (REFCOR) prospective study of 292 cases.

G. Calais, E. Baudin, E. Babin, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Outcomes and Side Effects of Preoperative Chemoradiotherapy for Locally Advanced Upper Rectal Cancer

G. Calais, P. Bourlier, S. Chapet, 2022, AntiCancer Research.

Squamous cell carcinoma of the base of the tongue: results of treatment in 115 cases.

G. Calais, P. Bougnoux, A. Reynaud-Bougnoux, 1989, The British journal of radiology.

Prognostic factors of extremity soft tissue sarcoma in adults. A single institutional analysis.

G. Calais, P. Garaud, P. Rosset, 2012, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Mediastinal large-cell lymphoma with sclerosis refractory to conventional chemotherapy can respond after daily oral cyclophosphamide.

G. Calais, P. Colombat, C. Linassier, 1998, Leukemia & lymphoma.

Radiation alone (RT) versus RT with concomitant chemotherapy (CT) in stages III and IV oropharynx carcinoma. Results of the 94.01 randomized study from the french group of radiation oncology for head and neck cancer (Gortec)

G. Calais, C. Sire, J. Tortochaux, 1998 .

40e réunion de l'American Society for Therapeutic Radiology and Oncology Phoenix (Arizona), 25–29 octobre 1998

G. Calais, J. Bachaud, E. Lartigau, 1999 .

Randomized Study Comparing Adjuvant Radiotherapy (RT) with Concomitant Chemotherapy (CT) Versus Sequential Treatment after Conservative Surgery for Patients with Stages I and II Breast Carcinoma: Long-term Results

G. Calais, J. Bosset, A. Fourquet, 2002 .

Relationship between 5-fluorouracil exposure and outcome in patients receiving continuous venous infusion with or without concomitant radiotherapy.

G. Calais, B. Giraudeau, F. Denis, 2007, British journal of clinical pharmacology.

Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trials.

V. Grégoire, G. Calais, J. Bourhis, 2017, Oral oncology.

Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation.

G. Calais, C. Sire, P. Garaud, 2016, Journal of the National Cancer Institute.

Randomized clinical trial of post-operative radiotherapy versus concomitant carboplatin and radiotherapy for head and neck cancers with lymph node involvement.

G. Calais, F. Baillet, M. Housset, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A well-tolerated 5-FU-based treatment subsequent to severe capecitabine-induced toxicity in a DPD-deficient patient.

G. Calais, J. Ciccolini, M. Boisdron-Celle, 2008, British journal of clinical pharmacology.

Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trial.

G. Calais, C. Sire, P. Garaud, 2020, European journal of cancer.

Sequential chemoradiotherapy (SCRT) for larynx preservation (LP): Results of the randomized phase II TREMPLIN study.

G. Calais, C. Sire, P. Garaud, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sequential chemoradiotherapy (SCRT) for larynx preservation (LP): Preliminary results of the randomized phase II TREMPLIN study.

G. Calais, C. Sire, D. de Raucourt, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predictors of distant recurrence in clinical stage I or II endometrial carcinoma treated by combination surgical and radiation therapy.

G. Calais, C. Moire, G. Body, 1997, Gynecologic oncology.

Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group.

Pierre Blanchard, Gilles Calais, Jean Bourhis, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma.

G. Calais, F. Denis, C. Sire, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

5500 ORAL Induction chemotherapy for larynx preservation. Updated results of the GORTEC 2000–01 randomized trial comparing docetaxel + cisplatinum + fluorouracil (TPF) versus cisplatinum + fluorouracil (PF)

G. Calais, S. Guérif, C. Sire, 2007 .

[Larynx preservation, state of the art].

G. Calais, J. Lefebvre, 2005, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

How does TPF improve survival over PF?

G. Calais, Y. Pointreau, I. Atean, 2011, The Lancet. Oncology.

[Normal tissue tolerance to external beam radiation therapy: larynx and pharynx].

G. Calais, J. Bourhis, C. Lafond, 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Robotic stereotactic body radiation therapy for tumors of the liver: radiation-induced liver disease, incidence and predictive factors.

G. Calais, Y. Pointreau, S. Chapet, 2014, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Docetaxel Plus Gemcitabine in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head And Neck: A Phase II Multicenter Study

G. Calais, C. Borel, D. Cupissol, 2007, American journal of clinical oncology.

Preliminary data of the GORTEC 2000-02 phase III trial comparing intravenous and subcutaneous administration of amifostine for head and neck tumors treated by external radiotherapy.

G. Calais, J. Bourhis, É. Bardet, 2002, Seminars in oncology.

Mapping of Recurrence Sites Following Adjuvant or Salvage Radiotherapy for Prostate Cancer Patients

G. Calais, S. Supiot, V. Seegers, 2022, Frontiers in Oncology.

Comparison of the efficacy and safety of miconazole 50‐mg mucoadhesive buccal tablets with miconazole 500‐mg gel in the treatment of oropharyngeal candidiasis

G. Calais, J. Daoud, R. Bensadoun, 2008 .

alpha-Linolenic acid content of adipose breast tissue: a host determinant of the risk of early metastasis in breast cancer.

G. Calais, S. Koscielny, C. Couet, 1994, British Journal of Cancer.

[Cutaneous angiosarcoma of the breast following surgery and irradiation of breast adenocarcinoma].

G. Calais, G. Body, J. Lansac, 1987, Journal de gynecologie, obstetrique et biologie de la reproduction.

Oncologic outcomes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in France.

G. Calais, E. Baudin, E. Babin, 2019, European journal of cancer.

151Can pilocarpine hydrochloride relieve xerostomia regardless of the destruction of major salivary glands? A prospective French cooperative study

J. Horiot, S. Schraub, G. Calais, 1996 .

Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial

G. Calais, U. Schick, O. Capitain, 2019, Radiation Oncology.

Subcutaneous compared with intravenous administration of amifostine in patients with head and neck cancer receiving radiotherapy: final results of the GORTEC2000-02 phase III randomized trial.

G. Calais, J. Bourhis, P. Garaud, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study.

Vincent Grégoire, Hervé Reychler, Max Lonneux, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group.

M. Piérart, L. Collette, G. Calais, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921.

Laurence Collette, Gilles Calais, L. Collette, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy with preoperative radiotherapy in rectal cancer.

Laurence Collette, Gilles Calais, L. Collette, 2006, The New England journal of medicine.

Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer

G. Calais, E. Gamelin, M. Boisdron-Celle, 2011, BMC Cancer.

Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group.

M. Piérart, G. Calais, J. Bosset, 2004, European journal of cancer.

Results of endocavitary irradiation of early rectal tumors.

J. Horiot, G. Calais, S. Roth, 1988, Acta oncologica.

Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial.

G. Calais, J. Bosset, P. Garaud, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

In reply to Drs. Munshi and Jalali

G. Calais, A. Fourquet, D. Azria, 2006 .

Cytotoxic drugs efficacy correlates with adipose tissue docosahexaenoic acid level in locally advanced breast carcinoma

G. Calais, E. Germain, V. Chajès, 1999, British Journal of Cancer.

Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer.

S. Schraub, G. Calais, T. Delozier, 2001, European journal of cancer.

Impact of Modern Management Strategies on the Clinical Outcome of Patients With Low Rectal Cancer – A Retrospective, Monocentric Cohort Study

G. Calais, D. Moussata, T. Lecomte, 2022, AntiCancer Research.

obotic stereotactic body radiation therapy for tumours of the liver : adiation-induced liver disease , incidence and predictive factors adiothérapie stéréotaxique des métastases hépatiques et des hépatocarcinomes : épatopathie radio-induite , incidence et facteurs prédictifs

G. Calais, Y. Pointreau, A. Ruffier-Loubière, 2014 .

Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems.

Fabrice Denis, Gilles Calais, G. Calais, 2003, International journal of radiation oncology, biology, physics.

Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma.

G. Calais, C. Sire, J. Tortochaux, 1999, Journal of the National Cancer Institute.

Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug group.

G. Calais, J. Habrand, R. de Crevoisier, 2018, European journal of cancer.

Intensity-modulated radiotherapy in head and neck cancer: results of the prospective study GORTEC 2004-03.

G. Calais, P. Giraud, R. Bensadoun, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Disappearance of the in situ component: a criterion predictive of metastasis in breast cancer after local relapse.

G. Calais, B. Chauvet, C. Le Péchoux, 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Induction chemotherapy in head and neck cancer: a new paradigm

G. Calais, J. Fayette, Y. Pointreau, 2011, Anti-cancer drugs.

Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for Stages IIB and III esophageal carcinoma: results of a pilot study.

G. Calais, L. de Calan, P. Bourlier, 1997, International journal of radiation oncology, biology, physics.

Oropharynx carcinoma: irradiation alone versus induction chemotherapy plus irradiation--5 year results.

G. Calais, P. Beutter, A. Reynaud-Bougnoux, 1990, British Journal of Radiology.

[Inner canthus--anatomical junction. A surgical entity].

G. Calais, L. Vaillant, D. Goga, 1990, Annales de chirurgie plastique et esthetique.

A large French multicenter retrospective series of T1-T2N0 vocal cords carcinomas treated with exclusive irradiation.

G. Calais, C. Lafond, P. Garaud, 2017, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Docetaxel Plus 5-Fluorouracil in Locally Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Phase II Multicenter Study

G. Calais, D. Cupissol, J. Dutin, 2004, American journal of clinical oncology.

Salvage stereotactic body radiotherapy for local prostate cancer recurrence after radiotherapy: a retrospective multicentre study of the GETUG.

G. Calais, P. Bondiau, R. de Crevoisier, 2019, International journal of radiation oncology, biology, physics.

Stereotactic body re-irradiation therapy for locally recurrent prostate cancer after external-beam radiation therapy: Initial report.

G. Calais, Y. Pointreau, G. Janoray, 2016, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy.

G. Calais, P. Colombat, C. Linassier, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Cytotoxic drug efficacy correlates with adipose tissue docosahexaenoic acid level in locally advanced breast carcinoma

G. Calais, E. Germain, V. Chajès, 2007, Lipids.

A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach.

V. Grégoire, G. Calais, P. Maingon, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[Radiotherapy of hypopharynx cancers].

G. Calais, P. Giraud, P. Maingon, 2016, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Radiotherapy of larynx cancers].

G. Calais, P. Giraud, P. Maingon, 2016, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Oropharyngeal cancer].

G. Calais, J. Bourhis, C. Lafond, 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Depression is associated with some patient‐perceived cosmetic changes, but not with radiotherapy‐induced late toxicity, in long‐term breast cancer survivors

G. Calais, V. Camus, P. Garaud, 2013, Psycho-oncology.

Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.

L. Collette, G. Calais, M. Bolla, 2014, The Lancet. Oncology.

Reirradiation of gliomas under stereotactic conditions: Prognostic factors for survival without relapse or side effects, a retrospective study at Tours regional university hospital (France).

G. Calais, Y. Pointreau, A. Ruffier, 2017, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

TPF: a rational choice for larynx preservation?

G. Calais, 2010, The oncologist.

Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm

G. Calais, G. Body, J. Lansac, 1994, Cancer.

Primary chemotherapy and radiosurgical breast-conserving treatment for patients with locally advanced operable breast cancers.

G. Calais, E. Lemarié, G. Body, 1993, International journal of radiation oncology, biology, physics.

Prognostic significance of breast relapse after conservative treatment in node-negative early breast cancer.

G. Calais, B. Chauvet, J. Lansac, 1990, International journal of radiation oncology, biology, physics.

[Epithelial cancer of the ovary in adults: prognostic and therapeutic study of 95 cases].

G. Calais, B. Chauvet, G. Body, 1990, Annales de chirurgie.

The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study.

G. Calais, S. Nénan, D. Peiffert, 2023, European Urology Oncology.

Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implications.

G. Calais, P. Garaud, A. de Muret, 1997, International journal of radiation oncology, biology, physics.

High-dose BCNU with ABMT followed by radiation therapy in the treatment of supratentorial glioblastoma multiforme.

G. Calais, P. Biron, P. Colombat, 1996, Bone marrow transplantation.

Survival outcomes, prognostic factors, and effect of adjuvant radiotherapy and prophylactic neck dissection in salivary acinic cell carcinoma: A prospective multicenter REFCOR study of 187 patients.

G. Calais, F. Clatot, E. Babin, 2023, European journal of cancer.

[Small cell carcinoma of the ovary. A clinical and anatomo-pathologic entity].

G. Calais, E. Lemarié, P. Colombat, 1993, Journal de gynecologie, obstetrique et biologie de la reproduction.

Radiation alone (RT) versus RT with concomitant chemotherapy (CT) in stages III and IV oropharynx carcinoma. final results of the 94-01 GORTEC randomized study

G. Calais, C. Sire, J. Tortochaux, 2001 .

Late toxicity results of randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma (GORTEC 94-01)

G. Calais, F. Denis, C. Sire, 2001 .

Carcinoma of the uterine cervix stage IB and early stage II. Prognostic value of the histological tumor regression after initial brachytherapy.

G. Calais, B. Chauvet, P. Bougnoux, 1989, International journal of radiation oncology, biology, physics.

Accelerated versus Conventional Radiotherapy with Concomitant Chemotherapy in Locally Advanced Head and Neck Carcinomas: Results of a Phase III Randomized Trial

V. Grégoire, G. Calais, J. Bourhis, 2008 .

Stereotactic body radiotherapy for mediastinal lymph node with CyberKnife®: Efficacy and toxicity.

I. Barillot, G. Calais, Y. Pointreau, 2023, Cancer Radiothérapie.

Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial

G. Calais, U. Schick, O. Capitain, 2019, Radiation Oncology.

Chronic cervical radiation myelopathy diagnosed by MRI.

B. Gaymard, G. Calais, P. Cotty, 1989, Journal of neuroradiology. Journal de neuroradiologie.

Enhanced acute toxicity in oropharynx carcinoma treated with radiotherapy and concomitant cisplatin, 5-fluorouracil and mitomycin C.

G. Calais, S. Chapet, A. Reynaud-Bougnoux, 1996, European journal of cancer.

In situ tumour radiosensitization induced by clofibrate administration: single dose and fractionated studies.

G. Calais, D. Hirst, 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[Stereotactic body radiation therapy for hepatocellular carcinoma: Results from a retrospective multicentre study].

I. Barillot, G. Calais, R. de Crevoisier, 2019, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Cetuximab Pharmacokinetics Influences Overall Survival in Patients With Head and Neck Cancer.

G. Calais, G. Paintaud, D. Ternant, 2016, Therapeutic drug monitoring.

Chemotherapy with Preoperative Radiotherapy in Rectal Cancer

L. Collette, G. Calais, J. Bosset, 2007 .